These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4709160)

  • 1. Panel discussion: problems arising from differences in domestic and international regulations.
    Bull Parenter Drug Assoc; 1973; 27(3):126-38. PubMed ID: 4709160
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug problems and the Common Market. Personal views].
    Andersen AH
    Ugeskr Laeger; 1973 Jun; 135(25):1300-1. PubMed ID: 4800706
    [No Abstract]   [Full Text] [Related]  

  • 3. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15990-1. PubMed ID: 19507321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remarks at the Food and Drug Law Institute's 48th Annual Conference.
    Niedelman SM
    Food Drug Law J; 2005; 60(2):117-26. PubMed ID: 16097089
    [No Abstract]   [Full Text] [Related]  

  • 5. Transatlantic regulatory cooperation expanded.
    Hughes B
    Nat Rev Drug Discov; 2007 Aug; 6(8):589-90. PubMed ID: 17821826
    [No Abstract]   [Full Text] [Related]  

  • 6. Validation--mission completed?
    Sharp J
    J Parenter Sci Technol; 1993; 47(1):2-3. PubMed ID: 8445494
    [No Abstract]   [Full Text] [Related]  

  • 7. Special section. The evaluation of drugs: an international perspective.
    Int J Technol Assess Health Care; 1986; 2(4):613-708. PubMed ID: 10280881
    [No Abstract]   [Full Text] [Related]  

  • 8. ISO 9000. Policy implications for FDA. Taking the pulse of increasing global use of the ISO series of uniform quality standards by FDA regulated industries.
    Schwemer WL; Lynch MA
    J Parenter Sci Technol; 1993; 47(3):101-18. PubMed ID: 8360802
    [No Abstract]   [Full Text] [Related]  

  • 9. The International Conference on Harmonization common technical document--global submission format?
    Molzon JA
    Food Drug Law J; 2005; 60(3):447-51. PubMed ID: 16304749
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of standards is the name of the game.
    White PB
    Food Drug Law J; 1996; 51(2):337-8. PubMed ID: 11822327
    [No Abstract]   [Full Text] [Related]  

  • 11. Legalized importation of Canadian prescription drugs: short-term solution to a long-term problem.
    Teufel AT
    J Contemp Health Law Policy; 2006; 22(2):383-408. PubMed ID: 17117702
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problems of an international nature in the registration of drugs for veterinary use].
    Lorenzini RN
    Ann Ist Super Sanita; 1984; 20(4):271-4. PubMed ID: 6546274
    [No Abstract]   [Full Text] [Related]  

  • 13. International Conference on Harmonisation; Stability Data Package for Registration Applications in Climatic Zones III and IV; Stability Testing of New Drug Substances and Products; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Nov; 68(225):65717-8. PubMed ID: 14631936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA in the global village.
    Williams RD
    FDA Consum; 1992; 26(6):14-7. PubMed ID: 10119705
    [No Abstract]   [Full Text] [Related]  

  • 15. International Conference on Harmonisation; final recommendations on the revision of the permitted daily exposures for two solvents, n-methylpyrrolidone and tetrahydrofuran, according to the maintenance procedures for the guidance Q3C Impurities: Residual Solvents; Availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Nov; 68(219):64352-3. PubMed ID: 14619948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving international drug cooperation.
    Voss EH
    Am Pharm; 1980 Apr; NS20(4):8-9. PubMed ID: 7386381
    [No Abstract]   [Full Text] [Related]  

  • 17. International Conference on Harmonisation; guidance on Q9 Quality Risk Management; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jun; 71(106):32105-6. PubMed ID: 16795933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA inspections in Canada.
    Oliver EA
    J Parenter Sci Technol; 1991; 45(3):142-6. PubMed ID: 1886042
    [No Abstract]   [Full Text] [Related]  

  • 19. EC/FDA joint inspections.
    Nasto B
    Nat Biotechnol; 2008 Aug; 26(8):847. PubMed ID: 18688225
    [No Abstract]   [Full Text] [Related]  

  • 20. [Problems connected with the drug provision in the United States].
    Sloot HA
    Pharm Weekbl; 1969 Jul; 104(30):914-23. PubMed ID: 5800761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.